好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Therapeutic Benefit Of A HTT-Lowering Antisense Oligonucleotide Targeting The CAG-Repeat In The R6/2 Huntington’s Disease Mouse Model
Movement Disorders
(-)
297
Authors/Disclosures

PRESENTER 		No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Giles Campion, MD, PhD No disclosure on file
No disclosure on file